Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

The human-bait method is the internationally recognized gold standard for evaluating how long a mosquito repellent remains effective on human skin. By exposing repellent-treated skin to caged, host-seeking mosquitoes at timed intervals, laboratories determine the complete protection time (CPT) required for product registration, label claims, and quality control. This article explains the technical principles, sample types, test items, standard procedures, and applications of human-bait based repellent persistence testing.

Technical Overview

The human-bait method, often called the arm-in-cage assay, is the internationally recognized reference technique for measuring the persistence of mosquito repellent products applied to human skin. Host-seeking female mosquitoes locate human hosts through carbon dioxide, lactic acid and other skin volatiles, moisture, and body heat. Because these natural attractant cues cannot yet be fully replicated in the laboratory, live human volunteers provide the most biologically realistic challenge for evaluating how long a repellent keeps mosquitoes from landing and biting.

The principal result of the test is the complete protection time (CPT), defined as the elapsed time between product application and the first confirmed landing, probing, or biting event by test mosquitoes on the treated skin. CPT data directly support protection-duration label claims and constitute a core efficacy requirement for registering repellent products in most major jurisdictions.

The human-bait persistence test is codified in several national and international standards, including:

  • GB/T 13917.9-2009, the Chinese national standard for laboratory efficacy testing of repellents used in hygiene insecticide registration.
  • The WHO Guidelines for Efficacy Testing of Mosquito Repellents for Human Skin.
  • The US EPA Product Performance Test Guideline OCSPP 810.3700 for insect repellents applied to human skin.
  • European Union biocidal product regulations, under which skin repellents fall into product-type 19.

Testing Samples

Topical Skin Repellent Formulations

Aerosol and pump sprays, lotions, creams, gels, roll-ons, oils, sticks, and impregnated wipes intended for direct application to exposed skin. Both synthetic active ingredients, such as DEET, icaridin (picaridin), IR3535, and para-menthane-3,8-diol, and botanical actives such as citronella, geraniol, and lemon eucalyptus oils are routinely evaluated.

Extended-Release and Fortified Formulations

Microencapsulated actives, polymer matrix systems, and film-forming technologies engineered for long-lasting performance. These samples often require observation windows of 8 to 12 hours or longer to capture their full protection profile.

Repellent-Treated Wearables and Textiles

Repellent wristbands, adhesive patches, and repellent-treated fabrics can be assessed using adapted human-bait protocols, in which the device is worn at a defined distance from exposed skin and the residual protective effect over time is recorded.

Testing Items

Depending on the regulatory purpose and product positioning, the following efficacy parameters are measured:

  • Complete protection time (CPT), the key persistence indicator.
  • Landing inhibition rate on treated skin compared with untreated control skin.
  • Probing and biting inhibition over the full observation period.
  • Persistence after simulated real-use conditions, such as sweating, water immersion, or towel drying, for water-resistance claims.
  • Application dose verification, confirming that the test dose, commonly about 1.5 mL or 1.5 g of product per subject under GB/T 13917.9, matches intended consumer usage.

Testing Methods

Test Principle

A measured dose of the repellent is applied to a defined area of skin on the forearm or back of the hand of a volunteer. At predetermined intervals, the treated skin is exposed to a colony of hungry, host-seeking female mosquitoes inside a secure test cage, while an untreated control subject confirms that the mosquitoes are actively biting. The elapsed time until the repellent no longer prevents confirmed landing or biting is recorded as the protection time.

Test Insects

Tests use laboratory-reared, pathogen-free, nulliparous female mosquitoes that have never taken a blood meal, most commonly Aedes albopictus under GB/T 13917.9 and Aedes aegypti under WHO and EPA protocols. Colony quality is maintained through controlled rearing at approximately 25 to 28 degrees Celsius, 60 to 80 percent relative humidity, and a 14:10 light-to-dark photoperiod. Each cage typically holds 200 to 300 females.

Human Subjects and Ethical Safeguards

A minimum of three to five healthy adult volunteers normally participate, together with an untreated control subject. All trials are conducted with informed consent under an approved ethical framework. Volunteers must avoid perfumed cosmetics, alcohol, smoking, and other repellent exposures before testing, and any subject experiencing irritation may withdraw at any time. Medical supervision is available throughout the procedure.

Test Procedure

  • Verify mosquito responsiveness by exposing the untreated control skin first; the trial proceeds only if mosquitoes land and attempt to bite within the acceptance window, confirming colony aggressiveness.
  • Clean and dry the test skin area, apply the assigned dose of product evenly, and record the exact application time.
  • At each scheduled interval, typically every 30 or 60 minutes, insert the treated skin into the cage for a standardized observation period and record all landings, probings, and bites.
  • Continue sequential exposures until the protection failure criterion is met or until the maximum observation window for the claimed duration is reached.
  • Calculate the protection time for each subject and report individual values or the median with range, in accordance with the applied standard.

Evaluation Criteria

Protection is considered to have failed when mosquitoes begin to land, probe, or bite on the treated skin in a confirmed pattern, for example a biting event repeated in consecutive exposure periods or a defined landing count within a single exposure, depending on the standard followed. The protection time is taken as the interval immediately before the first confirmed failure. Label claims must not exceed the substantiated protection time, and results are generally rounded down to conservative whole-hour values such as 4, 6, or 8 hours.

Applications

  • Regulatory registration of repellents as hygiene insecticides with the ICAMA in China, and equivalent submissions to the US EPA and European authorities.
  • Substantiation of protection-duration label claims for consumer products sold through retail and e-commerce channels.
  • Research and development screening and benchmarking of formulations, active ingredients, and slow-release technologies.
  • Batch-to-batch quality control and supplier verification for contract manufacturers.
  • Procurement qualification for outdoor, travel, occupational health, and military mosquito-protection products.
  • Scientific studies on mosquito host-seeking behavior and novel repellent mode-of-action research.

Because laboratory human-bait data are generated with colonized mosquitoes under controlled conditions, they are frequently complemented by field trials against wild populations to complete a full efficacy dossier.

FAQ

Which mosquito species are used in the test?

Aedes albopictus is the standard species under GB/T 13917.9-2009, while WHO and EPA protocols primarily use Aedes aegypti. Species selection reflects the target vector profile of the intended market.

How many human volunteers are required?

Most protocols require a minimum of three to five test subjects plus an untreated control, with replicate trials to address inter-individual variability in skin chemistry and attractiveness to mosquitoes.

Is the human-bait test safe?

Yes, when performed under an approved ethics framework. Mosquitoes come from certified pathogen-free laboratory colonies, volunteers give informed consent after medical screening, and any subject may stop at any time.

What exactly counts as a test failure?

Failure is the first confirmed landing, probing, or biting event on treated skin as defined by the applied standard, for example a mosquito that lands and bites with the event repeated in the next exposure interval.

How long does the test take?

The observation phase lasts as long as the expected protection duration, from a few hours for short-acting sprays to 12 hours or more for extended-release formulations. Overall project turnaround, including colony preparation and reporting, is commonly two to four weeks.

How much sample is needed for testing?

Typically enough product for multiple replicate applications across all subjects and any repeat trials, commonly around 50 to 100 grams or milliliters per formulation, plus retained reference portions.

How does this method compare with field testing?

The human-bait cage assay provides controlled, reproducible persistence data ideal for registration and label claims, whereas field tests capture wild-species diversity and environmental variability. Regulatory dossiers often combine both.